| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/03/2004 | CN1478547A Collagen protein health protection capsule |
| 03/03/2004 | CN1478546A Synergistic action of ossification growth peptide and granule cell colony stimulating factor in hematopoiesis |
| 03/03/2004 | CN1478545A Use of compound interferon in the treating of SARS disease |
| 03/03/2004 | CN1478544A Use of polypeptide protein kind active substance in Arca inflate Roeve and its extraction method |
| 03/03/2004 | CN1478543A Therapeutic use of bactericidal/permeability improving protein product |
| 03/03/2004 | CN1478542A Oyster natural active peptide and its preparation method and its application in the preparation of anticancer medicine |
| 03/03/2004 | CN1478541A Design of high effect blood vessel production inhibitor and its application |
| 03/03/2004 | CN1478540A Medicinal composition for treating diabetes and its complication and viral hepatitis and its preparation method |
| 03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
| 03/03/2004 | CN1478468A Phosphatide protein composite film, gelatine capsule and its improved preparation method |
| 03/03/2004 | CN1140536C Minotopes and anti-mimotopes of human platelet glycoprotein Ib/Ix |
| 03/03/2004 | CN1140529C Aluminoxane sythesis empolying reduced amount of trialkylaluminium compound |
| 03/03/2004 | CN1140295C Platelet-special chimeric immunoglobulin and method of use thereof |
| 03/03/2004 | CN1140294C Use of VIP, analogues and fragments thereof for the treatment of neurodegemeratiue diseases |
| 03/03/2004 | CN1140264C Chewing gum containing colloidal bismuth subcitrate |
| 03/03/2004 | CN1140261C Use of compositions comprising stabilized biologically effective compounds |
| 03/02/2004 | US6699985 Administering a defibrotide |
| 03/02/2004 | US6699983 Use in identifying homologous genes, production of encoded kinase, modulating expression or function of encoded protein, gene therapy or mapping, prophylactic/therapeutic cancer treatment, or determining cell types based on expression |
| 03/02/2004 | US6699974 Reshaped human anti-HM 1.24 antibody |
| 03/02/2004 | US6699970 Mutacin I biosynthesis genes and proteins |
| 03/02/2004 | US6699968 Fusion protein that includes a functional heparin sulfate attachment sequece placed into other proteins that normally do not have haparan sulfate glycosaminoglycan chains; links functional domains to biological effector molecules |
| 03/02/2004 | US6699967 Used to treat, prevent, or delay a tissue proliferation-associated disorder |
| 03/02/2004 | US6699966 Proteins within the type E botulinum neurotoxin complex |
| 03/02/2004 | US6699965 Used for as a drug screening target; protein from rat and human brains |
| 03/02/2004 | US6699905 Comprising administering to the subject an effective anti-inflammatory amount of a pharmaceutical composition comprising a lipoxin a4 compound and a pharmaceutically acceptable carrier |
| 03/02/2004 | US6699897 Streptogramin derivatives, their preparation and compositions which contain them |
| 03/02/2004 | US6699869 β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
| 03/02/2004 | US6699856 Pyrazinones, compositions containing such compounds and methods of use |
| 03/02/2004 | US6699843 Method for treatment of tumors using nucleic acid ligands to PDGF |
| 03/02/2004 | US6699839 Treating bacterial infection by administering composition including isolated mutacin b-ny266 polypeptide, having specified amino acid sequence, and specified residues are capable of forming lanthionine or b-methyllanthionine bridges |
| 03/02/2004 | US6699838 Antiangiogenic peptides |
| 03/02/2004 | US6699837 Treatment of neurons with HGF |
| 03/02/2004 | US6699836 Vancomycin analogs |
| 03/02/2004 | US6699835 Formulation of boronic acid compounds |
| 03/02/2004 | US6699833 Pharmaceutical formulations for sustained drug delivery |
| 03/02/2004 | US6699832 May contain another compound to treat diabetes, sexual dysfunction, atherosclerosis, insulin resistance, impaired glucose tolerance, hypercholesterolemia or hypertriglyceridemia |
| 03/02/2004 | US6699690 Linked and controlling the expression of a heterologous enzyme, for example varicella zoster virus thymidine kinase or non-mammaliam cytosine deaminase |
| 03/02/2004 | US6699686 Modified nuclear glucocorticoid receptor, fusion protein, and DNA fragments coding for said receptor and said fusion protein |
| 03/02/2004 | US6699682 Assay for inhibitors of fatty-acid amide hydrolase |
| 03/02/2004 | US6699672 Heparanase specific molecular probes and their use research and medical applications |
| 03/02/2004 | US6699664 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 03/02/2004 | US6699660 Isolated nucleic acid identical to one expressed in response to seizure or ischemia |
| 03/02/2004 | US6699656 Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin |
| 03/02/2004 | US6699504 Drug delivery |
| 03/02/2004 | US6699500 Sustained-release preparation capable of releasing a physiologically active substance |
| 03/02/2004 | US6699496 Enzyme in a dosage form for oral use in mammals, enzyme-containing food material and method for administering the enzyme in a dosage form |
| 03/02/2004 | US6699493 Performing the transplant, and implanting in the eye a biodegradable drug delivery system comprising an immunosuppressant and a biodegradable polymer |
| 03/02/2004 | US6699490 Parenteral release into the circulatory system of a cow somatotropin using a given dosage and concentration; free of absorption modifying agents, which can cause tissue irritation at the injection site |
| 03/02/2004 | US6699481 Peptides for inhibition of herpes simplex virus entry |
| 03/02/2004 | US6699475 Recombinant pox virus for immunization against tumor-associated antigens |
| 03/02/2004 | US6699472 Method of treating allergic disorders |
| 03/02/2004 | US6699471 Biocompatible composition in the form of a gel for use in the treatment of, inflammation,tumors and bone disorders |
| 03/02/2004 | US6699469 Materials and methods for treating or preventing oxalate-related disease |
| 03/02/2004 | US6699468 Defective expression of the gamma 34.5 gene and the ribonucleotide reductase gene |
| 03/02/2004 | US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 03/02/2004 | US6699466 IL-16 antagonist peptides and DNA encoding the peptides |
| 03/02/2004 | US6699294 Injectable implants for tissue augmentation and restoration |
| 03/02/2004 | CA2229405C Methods for enhancing the production of interferon in cell culture |
| 03/02/2004 | CA2196906C Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 03/02/2004 | CA2149441C Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 02/26/2004 | WO2004017044A2 Chimeric protein |
| 02/26/2004 | WO2004016799A2 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER |
| 02/26/2004 | WO2004016788A1 Splicing-variant of the human p53 protein and use thereof in the production of pharmaceutical preparations for treating tumoural diseases |
| 02/26/2004 | WO2004016764A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 02/26/2004 | WO2004016763A2 Treatment of holocrine gland dysfunction with clostridia neurotoxins |
| 02/26/2004 | WO2004016762A2 Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer |
| 02/26/2004 | WO2004016761A2 Gene therapy for critical limb ischemia with wild type or mutant enos |
| 02/26/2004 | WO2004016754A2 ANTISENSE MODULATION OF Nav1.3 EXPRESSION |
| 02/26/2004 | WO2004016749A2 Antisense modulation of acyl-coa synthetase 1 expression |
| 02/26/2004 | WO2004016746A2 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a c-myc protein |
| 02/26/2004 | WO2004016744A2 Treatment of liver deseases |
| 02/26/2004 | WO2004016739A2 Cell modulation using a cytoskeletal protein |
| 02/26/2004 | WO2004016737A2 Novel htnfsf13b protein variants |
| 02/26/2004 | WO2004016736A2 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer |
| 02/26/2004 | WO2004016735A2 Modulation of biological signal transduction by rna interference |
| 02/26/2004 | WO2004016734A2 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer |
| 02/26/2004 | WO2004016733A2 Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
| 02/26/2004 | WO2004016726A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 02/26/2004 | WO2004016653A2 Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase |
| 02/26/2004 | WO2004016650A1 Antimicrobial peptides, polypeptides comprising same, genes coding for said peptides, vectors, transformed organisms and compositions containing same |
| 02/26/2004 | WO2004016648A1 Fluorescent protein |
| 02/26/2004 | WO2004016647A2 Fragments of proinsulin c-peptide |
| 02/26/2004 | WO2004016646A2 Peptide modulators of tumour specific pyruvate kinase subtype m2 (m2-pk) |
| 02/26/2004 | WO2004016643A2 Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| 02/26/2004 | WO2004016641A2 Proteins involved in the regulation of energy homeostasis |
| 02/26/2004 | WO2004016279A1 Modulation of immune function |
| 02/26/2004 | WO2004016278A1 Methods for enhancing immune functions in neonatal mammals by administration of il-18 |
| 02/26/2004 | WO2004016263A1 Use of treosulfan and derivatives thereof for treating multiple sclerosis |
| 02/26/2004 | WO2004016244A2 Pharmaceutical compositions for buccal delivery of pain relief medications |
| 02/26/2004 | WO2004016243A2 Methods of administering and enhancing absorption of pharmaceutical agents |
| 02/26/2004 | WO2004016230A2 Identification of the endothelial receptor for the angiostatin kringle-5 |
| 02/26/2004 | WO2004016224A2 Antisense modulation of vegf co-regulated chemokine-1 expression |
| 02/26/2004 | WO2004016211A2 Pi3k antagonists as radiosensitizers |
| 02/26/2004 | WO2004016151A2 Pthrp-derived modulators of smooth muscle proliferation |
| 02/26/2004 | WO2004016148A2 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors |
| 02/26/2004 | WO2004005341A3 Full-length interferon gamma polypeptide variants |
| 02/26/2004 | WO2004005336A3 β-SHEET BREAKING PEPTIDES |
| 02/26/2004 | WO2004005328A3 Peptidomimetic compound useful as inhibitor of integrins |
| 02/26/2004 | WO2004004763A3 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 02/26/2004 | WO2004003218A3 Antisense modulation of hypothetical protein loc51249 expression |